The treatment-related Grade III TEAEs recorded were lowered neutrophil count [n = 11 (8.5%)], decreased white blood cell count [n = 6 (4.7%)], increased alanine transaminase (ALT) [n = 1 (0.8%)] and AST [n = 1 (0.8%)], and hypertriglyceridemia [n = 1 (0.8%)]. Here, GPT is linked to hypertriglyceridemia.